Clinical Trial Update: Methylene Blue in Severe Sepsis and Septic Shock [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for methylene blue in severe sepsis and septic shock.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Septic Shock

Drugs mentioned

• METHYLENE BLUE (METHYLENE BLUE)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Severe Sepsis, Septic Shock | Phase 3 | Status: UNKNOWN